The Value Signal — June 27, 2026

685 articles scanned · 13 high-signal

Signal Map

Executive Summary

VBC risk is shifting from retrospective coding cleanup to prospective control, while Washington tightens the vise on Medicare Advantage, Medicaid financing and utilization management.

Risk adjustment and Medicare Advantage are converging into a higher-stakes enforcement and network-access cycle: Optum argues plans are moving “left” into prospective risk adjustment to identify documentation gaps earlier, while Modern Healthcare reports Elevance paid CMS $342 million amid a Medicare Advantage probe. Healthcare Brew reports cancer patients in Medicare Advantage accessed fewer providers than traditional Medicare patients, and American Hospital Association warns MedPAC’s lens on Medicare Advantage’s hospital-finance impact is incomplete.

Program integrity, Medicaid and prior authorization are becoming the policy battleground for 2026 VBC economics: Hooper, Lundy & Bookman flags proposed Medicaid financing limitations under Section 71116, Healthcare Dive reports state Medicaid directors defended program integrity as Democrats challenged selective funding threats, and Asco is soliciting input on Medicaid work requirements. AMA reports House health-panel momentum on prior authorization reform, Home Health Care News says CMS precedent and midterm politics point toward extending the home health enrollment moratorium, and HFMA details the proposed rule to codify Medicare drug-price negotiation and related Part D policies under the Inflation Reduction Act.